Sanofi
CIK 1121404 · last filed 2021-09-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.17B
Companies
11
Total Filings
65
Lifetime Open-Market Net
-$2.44B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TBIO | 10%+ Owner | 55,152,046 | $0.00 | $5.5K | $2.74B | 1 | 2021-09-14 |
| Icosavax, Inc. (ICVX) Delisted | 10%+ Owner | 3,155,169 | $15.31 | $48.31M | $1.00M | 1 | 2021-08-02 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 438,875 | $4.00 | $1.76M | $1.30M | 1 | 2020-07-29 |
| REGN | 10%+ Owner | 279,766 | $612.14 | $171.26M | -$9.52B | 46 | 2020-06-11 |
| FULC | 10%+ Owner | 464,285 | $3.45 | $1.60M | $1.50M | 1 | 2019-07-23 |
| MyoKardia, Inc. (MYOK) Delisted | 10%+ Owner | 0 | — | — | -$121.48M | 5 | 2019-02-15 |
| ALNY | 10%+ Owner | 10,554,134 | $282.85 | $2.99B | $1.98B | 6 | 2017-06-01 |
| VYGR | 2,352,941 | $3.50 | $8.24M | $1.75M | 1 | 2015-11-18 | |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 5,053,779 | $8.16 | $41.24M | $10.00M | 1 | 2014-02-05 |
| HUMANIGEN, INC (KBIO) Delisted | 579,030 | — | — | $700.0K | 1 | 2013-02-07 | |
| GENZYME CORP (GENZ) Delisted | 10%+ Owner | 187,986,225 | — | — | $2.48B | 1 | 2011-04-08 |
Recent Filings · Page 2 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-10 | REGN | Sell (S) | −104,552 | -$42.52M | EDGAR |
| 2018-06-11 | REGN | Sell (S) | −121,601 | -$37.61M | EDGAR |
| 2018-05-29 | MyoKardia, Inc. (MYOK) Delisted | Buy (P) | +150,000 | $7.35M | EDGAR |
| 2017-08-29 | REGN | Buy (P) | +72,378 | $34.84M | EDGAR |
| 2017-08-25 | REGN | Buy (P) | +166,415 | $80.03M | EDGAR |
| 2017-08-16 | MyoKardia, Inc. (MYOK) Delisted | Buy (P) | +350,000 | $12.43M | EDGAR |
| 2017-06-06 | REGN | Buy (P) | +136,050 | $65.06M | EDGAR |
| 2017-06-01 | ALNY | Buy (P) | +297,501 | $21.38M | EDGAR |
| 2017-01-13 | REGN | Buy (P) | +87,298 | $32.27M | EDGAR |
| 2016-10-05 | MyoKardia, Inc. (MYOK) Delisted | Buy (P) | +450,000 | $6.75M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.